You finally found a hormone therapy routine that works. You are sleeping through the night. The hot flashes have quieted. You feel like yourself again. And now your pharmacy is telling you your estrogen patch is on backorder.

This is not in your head. This is happening everywhere, and it deserves a direct explanation.

The conversation around menopause and perimenopause has exploded over the past several years, among physicians, educators, and women themselves. More patients are asking about hormone therapy. More clinicians are prescribing it. That is exactly what should be happening. The problem is that supply has not kept pace, and women who finally found relief are now being left to scramble.

Let me tell you what is driving this, what your options are, and what I would tell you if you were sitting in my office today.

Why This Is Happening Now

In November 2025, the FDA removed the black box warning on estrogen therapy for menopause. That decision was a long time coming, and it was the right call. It validated what many of us have known for years. Estrogen is safe. The warning itself was a direct consequence of the 2002 Women’s Health Initiative study, which linked hormone therapy to breast cancer and cardiovascular risk in ways that later research showed were significantly overstated. The damage, however, was already done. A generation of women was told to tough it out, and a generation of clinicians, myself included, became overly cautious in ways that did not serve our patients.

When that warning came down, demand for estrogen therapy jumped. Prescriptions for estrogen-based therapy among women ages 45 to 54 rose 184 percent between 2018 and 2026, with a 20 percent increase in just the seven months between July 2025 and February 2026. That is not a gradual trend. That is a surge. And manufacturers, who plan their production months in advance in tightly scheduled batches, simply could not move fast enough to keep shelves stocked.

Patches are feeling the squeeze more than other forms because women prefer them, and for good reason. They are cost-effective. They have a strong safety profile. Insurance is more likely to cover them. Patches send estradiol directly through the skin, bypassing the liver entirely, which avoids the clot risk associated with oral estrogen. More women starting hormone therapy and staying on it longer means more monthly refills drawing from the same limited supply.

As of the American Society of Health-System Pharmacists April 2026 bulletin, several specific products are affected, including Dotti, Lyllana, Noven, and Zydus estradiol patches. Some have no estimated restock date. Manufacturers including Amneal have acknowledged there is finite industry capacity for producing these patches, and supply chain pressures, including tariffs on overseas manufacturing, are adding stress to an already strained system. The FDA has said supply is keeping up, but barely. That qualifier matters, and women trying to fill prescriptions are feeling it every day.

What You Should Do Right Now

The first thing I want you to know is that a short interruption in hormone therapy is uncomfortable, but it is not dangerous. Hot flashes may return. Sleep may suffer. Those symptoms are real and they are disruptive, but they are not signs of harm. What you should not do is ration patches, cut them, or re-wear them to stretch your supply. That changes your dose in unpredictable ways, and inconsistent dosing is worse than a brief pause.

Call around to pharmacies before you do anything else. Supply varies significantly by location and distributor. A pharmacy two miles away may have exactly what your usual one cannot fill. Independent and specialty pharmacies often carry stock that the major chains have run out of, and they are worth the call.

If you cannot find your patch, talk to your doctor about a same-dose alternative from a different manufacturer. Sandoz and Viatris still have estradiol patches available in some markets. If the twice-weekly patch you use is out of stock, a once-weekly version at the equivalent dose may be available. Your doctor can do that math.

If no patch is available at any dose from any manufacturer in your area, the conversation shifts to form, not hormone. Gels, creams, and sprays deliver estradiol through the skin the same way a patch does. The mechanism is identical. The difference is that most require daily application, and insurance coverage is sometimes less reliable. That is a real tradeoff worth discussing. Oral estrogen is another option for women without a clot history. It is easy to find, simple to take, and there is solid data showing it can support cholesterol levels. If you still have a uterus, oral estrogen is paired with progesterone to protect the uterine lining. Before prescribing a pill, any responsible clinician will review your clot history, migraine history, blood pressure, and smoking status.

For women whose primary symptoms are vaginal dryness, pain with intercourse, or recurrent urinary tract infections, localized estrogen may actually be a better fit than systemic therapy regardless of the shortage. A vaginal ring or vaginal estrogen cream treats symptoms directly at the source without affecting the whole body. This is not a compromise. For some women, it is the more appropriate clinical choice.

What I Want You to Take Away From This

Women went without hormone therapy for decades because of a study whose conclusions were misapplied and whose risks were overstated. We are finally correcting that. Demand rising is a sign that the system is working better than it was. The failure here is not that women are finally getting care. The failure is that the infrastructure was not built to support them when they arrived.

You should not have to fight for access to one of the safest and most effective treatments available to you. You should not have to navigate backorders and substitutions and insurance denials alone. You deserve complete information, a clinical partner who takes your symptoms seriously, and a treatment plan that does not disappear the moment demand outpaces a manufacturer’s production schedule.

If your patch is out of stock, you have options. Use them. And if your current provider is not helping you find them, find a provider who will.

Because if it is predictable, it is preventable.